Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Quick Stats
Jan 30, 202653.6
AI Score
HOLD0.84
Volume Ratio
Mar 12, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
CADL Stock Summary
Last updated Jan 30, 2026
CADL is currently trading at $5.84, positioned above its 200-day moving average of $5.5, indicating a long-term uptrend. The stock has a 52-week range of $4.25 to $13.68.
Technical Analysis: The 50-day moving average stands at $5.54, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 49.496, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.055, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CADL at 53.6/100 with a HOLD recommendation.
CADL (Candel Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 49.496 |
| CMF (20) | -0.055 |
| ROC (10) | -1.683 |
| ADX (14) | 27.133 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.093 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -71.56 |
| MFI (14) | 60.309 |
CADL Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CADL Price vs Max Options Open Interest
CADL Max Change In Options Open Interest
CADL Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CADL Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CADL Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CADL Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Candel Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
CADL Moving Averages Analysis
Candel Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Candel Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
CADL (Candel Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 6.07 |
| 20 | 5.9 |
| 30 | 5.86 |
| 50 | 5.54 |
| 100 | 5.43 |
| 200 | 5.5 |
CADL Fundamental Analysis
| P/E (Forward) | 43.4783 |
| P/E (Trailing) | -- |
| Market Cap ($) | 315.1 million |
| Earnings/Share ($) | -0.56 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.625 |
| EPS Estimate Next Year ($) | -0.6 |
| WallStreet Target Price ($) | 18.625 |
| Most Recent Quarter |
The stock $CADL saw a positive trend on a red market day, with investors speculating about a potential partnership with GSK. The stock closed over $7.00 and there is anticipation for partnership news next week that could potentially lead to an opening price of $18 or higher. Shorts are feeling nervous about the stock's potential.
Updated 2025-12-12 15:00:02